Literature DB >> 30220056

Predication of post-operative outcome of colectomy in ulcerative colitis patients using Model of End-Stage Liver Disease Score.

Nan Lan1,2, Bo Shen2, Jianping Wang3.   

Abstract

PURPOSE: Model of End-Stage Liver Disease (MELD) score was developed to predict mortality in patients with liver disease. The aim of this study was to investigate the relationship between preoperative MELD score and 30-day surgical outcomes using the American College of Surgeons National Surgical Quality Improvement Program.
METHODS: Patients with ulcerative colitis (UC) (ICD: 556.X) who underwent colectomy were identified from NSQIP 2005 to 2013. The primary outcomes were bleeding complications, and overall morbidity and mortality.
RESULTS: A total of 7534 UC patients undergoing colectomy were identified. Patients with a higher MELD score had a longer hospital stay; more bleeding; and cardiac, respiratory, renal, thromboembolic, and septic complications as well as mortality. Patients were stratified into 4 groups by MELD score: < 7, 7-11, 12-15, and > 15 and a stratified multivariate analysis was done. Patients with a MELD score 12-15 (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.1-1.3) and MELD > 15 (OR 2.6, 95%CI 1.5-4.7) were at significant risk for bleeding complication. Apart from the MELD score, the presence of ascites (OR 2.5, 95%CI 1.2-5.1) or varices (OR 1.0, 95%CI 1.01-1.03) was also significantly associated with post-operative bleeding complication. MELD 12-15 and MELD > 15 were also found to be risk factors for overall morbidity (OR 5.3, 95%CI 1.8-15.7; OR 10.3, 95%CI 3.6-29.7, respectively) and mortality (OR 3.3, 95%CI 1.3-8.4; OR 5.9, 95%CI 2.4-14.6, respectively).
CONCLUSION: UC patients with a higher MELD score were associated with a higher post-colectomy morbidity and mortality. MELD score > 11 was an independent indicator for post-operative bleeding, and overall complications and mortality.

Entities:  

Keywords:  Bleeding; Liver disease; Model for End-Stage Liver Disease; Proctocolectomy; Ulcerative colitis

Mesh:

Year:  2018        PMID: 30220056     DOI: 10.1007/s00384-018-3147-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  19 in total

1.  Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy.

Authors:  A H Kartheuser; R R Dozois; N F LaRusso; R H Wiesner; D M Ilstrup; C D Schleck
Journal:  Mayo Clin Proc       Date:  1996-08       Impact factor: 7.616

2.  Model for End-stage Liver Disease (MELD) in predicting postoperative mortality of patients undergoing colorectal surgery.

Authors:  Traci L Hedrick; Brian R Swenson; Charles M Friel
Journal:  Am Surg       Date:  2013-04       Impact factor: 0.688

3.  Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy.

Authors:  M N Eade
Journal:  Ann Intern Med       Date:  1970-04       Impact factor: 25.391

4.  Relationship between model for end-stage liver disease score and 30-day outcomes for patients undergoing elective colorectal resections: an American college of surgeons-national surgical quality improvement program study.

Authors:  Erin O Lange; Christine C Jensen; Genevieve B Melton; Robert D Madoff; Mary R Kwaan
Journal:  Dis Colon Rectum       Date:  2015-05       Impact factor: 4.585

5.  Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?

Authors:  Lei Lian; K V Narayanan Menon; Bo Shen; Feza Remzi; Ravi P Kiran
Journal:  Dis Colon Rectum       Date:  2012-01       Impact factor: 4.585

Review 6.  Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

7.  Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores.

Authors:  Hannes Neeff; Dimitri Mariaskin; Hans-Christian Spangenberg; Ulrich T Hopt; Frank Makowiec
Journal:  J Gastrointest Surg       Date:  2011-01       Impact factor: 3.452

Review 8.  Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.

Authors:  E Gizard; A C Ford; J-P Bronowicki; L Peyrin-Biroulet
Journal:  Aliment Pharmacol Ther       Date:  2014-05-11       Impact factor: 8.171

9.  Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.

Authors:  Lisa S Poritz; Walter A Koltun
Journal:  Dis Colon Rectum       Date:  2003-02       Impact factor: 4.585

10.  Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis.

Authors:  K L Mathis; E J Dozois; D W Larson; R R Cima; J M Sarmiento; B G Wolff; J K Heimbach; J H Pemberton
Journal:  Br J Surg       Date:  2008-07       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.